UnitedHealth Group (NYSE:UNH) Issues FY20 Earnings Guidance

Henrietta Strickland
December 5, 2019

Insiders sold 683,893 shares of company stock valued at $23,455,346 over the last three months.

Several other institutional investors and hedge funds have also modified their holdings of MKC. LLC grew its position in UnitedHealth Group by 212.5% during the 3rd quarter. Nuveen Asset Management LLC increased its stake in UnitedHealth Group by 1,354.6% in the second quarter. Par Capital Management Inc. raised its holdings in Expedia Group by 19.4% in the 2nd quarter. Expedia Group's quarterly revenue was up 2.8% compared to the same quarter past year. Delta Asset Management LLC TN boosted its holdings in shares of UnitedHealth Group by 111.0% in the third quarter. Prestige Wealth Management Group LLC now owns 1,607 shares of the healthcare conglomerate's stock valued at $349,000 after buying an additional 209 shares in the last quarter. Finally, CSat Investment Advisory L.P. raised its position in shares of MCCORMICK & CO /SH by 171.2% during the 2nd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate's stock worth $35,000 after acquiring an additional 122 shares in the last quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. The firm has a market cap of $21.96 billion, a P/E ratio of 48.42, a P/E/G ratio of 4.05 and a beta of 1.16. The company has a quick ratio of 1.54, a current ratio of 2.10 and a debt-to-equity ratio of 0.40. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The stock's fifty day moving average price is $260.30 and its two-hundred day moving average price is $245.75.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The company reported $1.46 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.29 by $0.17. The UnitedHealth Group Incorporated having its distance from 20-days simple moving average is 5.40%, and its distance from 50-days simple moving average is 14.01%, while it has a distance of 14.54% from the 200-days simple moving average. The company had revenue of $1.80 billion during the quarter, compared to analysts' expectations of $1.81 billion. As a group, equities analysts expect that Advanced Micro Devices, Inc. will post 0.46 EPS for the current fiscal year. The firm's revenue was up.8% on a year-over-year basis.

Earnings-per-Share (EPS) is the portion of a UnitedHealth Group Incorporated profit that is asignto each outstanding share of its common stock. Investors of record on Monday, December 9th will be paid a $1.08 dividend. This represents a $3.80 annualized dividend and a yield of 2.73%.

Chevy Chase Trust Holdings Inc. increased its stake in Msci Inc (NYSE:MSCI) by 30.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The stock was sold at an average price of $129.00, for a total transaction of $961,050.00. Following the completion of the sale, the chief accounting officer now directly owns 28,017 shares in the company, valued at approximately $3,147,429.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO M. Andrew Wade sold 11,705 shares of the stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $38.63, for a total value of $32,101.53. The institutional investor owned 57,088 shares of the company's stock after acquiring an additional 4,904 shares during the period. The disclosure for this sale can be found here. Insiders own 11.00% of the company's stock.

Several research firms have commented on UNH.

UnitedHealth Group (NYSE:UNH) stock changed position at -0.986916% to closing price of $276.9 on last trading session (Tuesday). UBS Group downgraded shares of United Rentals from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $166.00 to $118.00 in a research note on Tuesday, October 8th. Cantor Fitzgerald lifted their price target on UnitedHealth Group from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and thirteen have assigned a buy rating to the company's stock.

Analyst Views: Fluctuating the focus to what the Wall Street analysts are projecting, we can see that the current consensus target price on shares is $14.

McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry. The company operates in two segments, Computing and Graphics; and Enterprise, Embedded and Semi-Custom. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER